HIV-1 particles assembling at the surface of an infected macrophage
|
|
HIVtc meets the HIV/AIDS training needs of pharma, biotech National, State and local governments and non-profit organizations. Our courses target clinically trained and non-specialists staff who require broad or specific knowledge of HIV/AIDS. Examples of our trainings include courses in HIV treatment and care, antiretroviral resistance, HCV co-infection and HIV, substance use and mental health, and new antiretroviral agents in clinical trials. HIVtc instructors are established specialists in the clinical management of HIV, HIV epidemiology and the political economy of the HIV sector.
|
 |
| HIV Prevalence, World Wide 2006 |
|
|
SELECTED COURSES
Overview Epidemiological and Social History HIV Worldwide: This course reviews the (1) epidemiology of HIV world wide (2) examines trends in patterns of HIV transmission by region; (3) discusses the availability and type of ARV medications across developing and developed nations, and;(4) lastly, describes cutting edge HIV prevention initiatives and technologies underdevelopment such as microbicide development, pre-exposure prophylaxis and pooled viral load testing.The Mind of the HIV Provider: This course reviews the principal factors that go into Providers' decision making processes for initiating ARV therapy, managing ARV side effects and co-morbidities, such as chronic hepatitis, substance abuse and malignancies. Lastly, this course will analyze how HIV providers interpret treatment guidelines in their approach to subsequent treatment options in patients with sub-optimal adherence and/or drug resistant HIV. What's New in HIV Treatment: This course provides the treatment updates from the most recent scientific conferences for HIV such as ICAAC and CROI. Instructors discuss and contrast emerging advances with past and current HIV treatment protocols.
Co-Infection and HIV: This course reviews major co-infections including the hepatitides (B and C) and tuberculosis (TB). Instructors review treatments for hepatitis B and C and TB, emphasizing interactions between ARV medications and TB medications.
HIV Resistance: This course reviews ARV resistance profiles, discusses the molecular dynamics governing the development of drug resistance and cross resistance. Participants learn to interpret phenotypic and genotypic tests and to optimize strategies for enhancing the effectiveness of ARV therapy and minimize resistance.
Mental Health and HIV: The more HIV has become a chronic disease,the more prominent mental health concerns are becoming for clinicians treating HIV disease. This course discusses the major mental health disorders facing patients, emphasizing interaction between mental health sequelae and HIV such as depression, psychosis, substance abuse, ARV treatment, and treatment adherence.
Understanding Phenotype, Genotype and Trofile assays: This course takes participants through a step by step process of how phenotype, genotype and trofile assays are conducted in the laboratory. Participants also learn how providers use resistance testing in combination with patients' ARV treatment history to make decisions regarding potent and durable treatment options. Patient Panels: In this interactive course participants will hear a panel of patients present their perspectives of living with HIV and allow participants to ask questions about their experiences.
|
|